ALGN vs ENOV: stock comparison and AI forecast
Align Technology Inc (ALGN) and Enovis Corp (ENOV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ALGN Align Technology Inc
- Market Cap
- $11.79B
- P/E Ratio
- 24.2x
- Size
- large-cap
- AI Forecast
ENOV Enovis Corp
- Price
- $27.16 -0.3% · 6M
- Market Cap
- $1.57B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ALGN is 7.5 times larger than ENOV by market capitalization ($11.79B against $1.57B).
- ALGN turns 11.8% of its revenue into net income, against -22.9% for ENOV.
- ENOV carries 1.50 times debt per unit of equity, against 0.51 times for ALGN.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ALGN | ENOV |
|---|---|---|
| Market Cap | $11.79B | $1.57B |
| P/E Ratio | 24.20x | – |
| P/B Ratio | 2.74x | 1.05x |
| EPS | $6.86 | $-10.06 |
| Book Value/Share | $60.61 | $25.89 |
| Revenue/Share | $58.54 | $39.99 |
| FCF/Share | $8.48 | $1.21 |
Profitability & Margins
| Metric | ALGN | ENOV |
|---|---|---|
| ROE | 11.4% | -35.3% |
| ROA | 7.5% | -14.1% |
| ROIC | 13.5% | -15.1% |
| Gross Margin | 69.1% | 61.3% |
| Operating Margin | 14.9% | -20.6% |
| Net Margin | 11.8% | -22.9% |
| EBT Margin | 15.5% | -21.8% |
| Tax Rate | 23.6% | -5.0% |
Financial Health
| Metric | ALGN | ENOV |
|---|---|---|
| Current Ratio | 1.42x | 2.15x |
| Quick Ratio | 1.31x | 1.08x |
| D/E Ratio | 0.51x | 1.50x |
| Financial Leverage | 1.51x | 2.50x |
| Interest Coverage | 518.2x | 0.4x |
| Working Capital | $813M | $668M |
Cash Flow
| Metric | ALGN | ENOV |
|---|---|---|
| Operating Cash Flow | $750M | $259M |
| Free Cash Flow | $602M | $70M |
| Capital Spending | -$147M | -$189M |
| OCF Growth YoY | 14.3% | 19.3% |
| FCF Growth YoY | 6.3% | 205.6% |
| FCF/Sales | 14.5% | 3.0% |
| CapEx/Sales | 3.5% | 8.2% |
Operational Efficiency
| Metric | ALGN | ENOV |
|---|---|---|
| Asset Turnover | 0.64x | 0.62x |
| Receivables Turnover | 3.6x | 5.4x |
| Inventory Turnover | 5.7x | 1.4x |
| Fixed Assets Turnover | 3.7x | 4.4x |
| Days Sales Outstanding | 102 days | 68 days |
| Days Inventory | 64 days | 254 days |
| Payables Period | 34 days | 82 days |
| Cash Conversion Cycle | 133 days | 239 days |
Income Statement
| Metric | ALGN | ENOV |
|---|---|---|
| Total Revenue | $4.16B | $2.31B |
| Operating Income | $620M | -$475M |
| Net Income | $492M | -$527M |
| R&D Expense | $378M | $126M |
| SG&A Expense | $1.78B | $1.08B |
| Cost of Goods Sold | $1.28B | $892M |
Dividend & Shareholder Information
| Metric | ALGN | ENOV |
|---|---|---|
| Shares Outstanding | 71M | 58M |
| Net Income Growth | 30.0% | – |
| EPS Growth | 32.7% | – |
ALGN vs ENOV: stock comparison and AI forecast
Which is bigger, ALGN or ENOV?
ALGN is 7.5 times larger than ENOV by market capitalization ($11.79B against $1.57B).
Which one does Intratio's AI model rank higher, ALGN or ENOV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.